Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Condition(s): Endometrial Adenocarcinoma; Endometrial Adenosquamous Cell Carcinoma; Endometrial Clear Cell Carcinoma; Recurrent Endometrial Carcinoma; Stage III Endometrial Carcinoma; Stage IV Endometrial Carcinoma Last Updated: February 5, 2013Active, not recruiting